Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AVTX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
AVTX
Avalo Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
AVTX
Avalo Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
AVTX
Avalo Therapeutics, Inc.
Change
6.96
▲
+4.99%
Mkt cap
$383.4M
Revenue
$59,000
Q4 FY25
Revenue
—
LLY
ELI Lilly & Co
Change
1,367.41
▲
+0.20%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
AVTX
Avalo Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
6.96
▲
+4.99%
Price
1,367.41
▲
+0.20%
$383.4M
Mkt cap
$1.2T
Q4 FY25
$59,000
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
AVTX
6.96
▲
+4.99%
vs
LLY
1,367.41
▲
+0.20%
Regular session
Nov 6 '26
Co-movers
daily closes
Method
›
Moved together
AVTX
with
LLY
No shared trading history for AVTX and LLY.
Shared co-movers: not yet measured (AVTX).
AVTX, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes